Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Rho(D) Immune Globulin Market Insights, Forecast to 2030

Global Rho(D) Immune Globulin Market Insights, Forecast to 2030

Industry: Pharma & Healthcare

Published Date: 2024-04-12

Pages: 90 Pages

Report ld: 2934732

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Rho(D) immune globulin (RhIG) is a medication used to prevent Rh isoimmunization in mothers who are Rh negative and to treat idiopathic thrombocytopenic purpura (ITP) in people who are Rh positive. It is often given both during and following pregnancy. It may also be used when Rh negative people are given Rh positive blood. It is given by injection into muscle or a vein. A single dose lasts 2 to 4 weeks.

The global Rho(D) Immune Globulin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Rho(D) Immune Globulin, also known as anti-Rh factor immunoglobulin, is a biological product used to prevent Rh hemolytic disease of the newborn in cases where an Rh-negative mother is carrying an Rh-positive fetus. In the market, driven by advancements in medical technology and awareness, there is a steady growth in demand for Rho(D) immune globulin. Currently, the product finds extensive application in the fields of prenatal care and obstetrics, particularly in high-risk pregnancies to prevent Rh hemolytic disease. With ongoing advancements in biologic manufacturing techniques, the future development of Rho(D) immune globulin might focus on refinement to enhance efficacy and reduce side effects, catering to the continually expanding market needs.

Report Covers:

This report presents an overview of global market for Rho(D) Immune Globulin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Rho(D) Immune Globulin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Rho(D) Immune Globulin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rho(D) Immune Globulin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Rho(D) Immune Globulin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Rho(D) Immune Globulin sales, projected growth trends, production technology, application and end-user industry.

MARKET SEGMENTATION

By Company

CSL Behring
Grіfоlѕ
Bayer
Kedrion Biopharma
Saol Therapeutics

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

5 ml
10 ml

Segment by Application

Government Institution
Private Sector
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Rho(D) Immune Globulin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Rho(D) Immune Globulin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rho(D) Immune Globulin sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Rho(D) Immune Globulin Product Introduction

1.2 Market by Type

1.2.1 Global Rho(D) Immune Globulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 5 ml

1.2.3 10 ml

1.3 Market by Application

1.3.1 Global Rho(D) Immune Globulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Government Institution

1.3.3 Private Sector

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Rho(D) Immune Globulin Sales Estimates and Forecasts 2019-2030

2.2 Global Rho(D) Immune Globulin Revenue by Region

2.2.1 Global Rho(D) Immune Globulin Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Rho(D) Immune Globulin Revenue by Region (2019-2024)

2.2.3 Global Rho(D) Immune Globulin Revenue by Region (2025-2030)

2.2.4 Global Rho(D) Immune Globulin Revenue Market Share by Region (2019-2030)

2.3 Global Rho(D) Immune Globulin Sales Estimates and Forecasts 2019-2030

2.4 Global Rho(D) Immune Globulin Sales by Region

2.4.1 Global Rho(D) Immune Globulin Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Rho(D) Immune Globulin Sales by Region (2019-2024)

2.4.3 Global Rho(D) Immune Globulin Sales by Region (2025-2030)

2.4.4 Global Rho(D) Immune Globulin Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Rho(D) Immune Globulin Sales by Manufacturers

3.1.1 Global Rho(D) Immune Globulin Sales by Manufacturers (2019-2024)

3.1.2 Global Rho(D) Immune Globulin Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rho(D) Immune Globulin in 2023

3.2 Global Rho(D) Immune Globulin Revenue by Manufacturers

3.2.1 Global Rho(D) Immune Globulin Revenue by Manufacturers (2019-2024)

3.2.2 Global Rho(D) Immune Globulin Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Rho(D) Immune Globulin Revenue in 2023

3.3 Global Key Players of Rho(D) Immune Globulin, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Rho(D) Immune Globulin Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Rho(D) Immune Globulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Rho(D) Immune Globulin, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Rho(D) Immune Globulin, Product Offered and Application

3.8 Global Key Manufacturers of Rho(D) Immune Globulin, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Rho(D) Immune Globulin Sales by Type

4.1.1 Global Rho(D) Immune Globulin Historical Sales by Type (2019-2024)

4.1.2 Global Rho(D) Immune Globulin Forecasted Sales by Type (2025-2030)

4.1.3 Global Rho(D) Immune Globulin Sales Market Share by Type (2019-2030)

4.2 Global Rho(D) Immune Globulin Revenue by Type

4.2.1 Global Rho(D) Immune Globulin Historical Revenue by Type (2019-2024)

4.2.2 Global Rho(D) Immune Globulin Forecasted Revenue by Type (2025-2030)

4.2.3 Global Rho(D) Immune Globulin Revenue Market Share by Type (2019-2030)

4.3 Global Rho(D) Immune Globulin Price by Type

4.3.1 Global Rho(D) Immune Globulin Price by Type (2019-2024)

4.3.2 Global Rho(D) Immune Globulin Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Rho(D) Immune Globulin Sales by Application

5.1.1 Global Rho(D) Immune Globulin Historical Sales by Application (2019-2024)

5.1.2 Global Rho(D) Immune Globulin Forecasted Sales by Application (2025-2030)

5.1.3 Global Rho(D) Immune Globulin Sales Market Share by Application (2019-2030)

5.2 Global Rho(D) Immune Globulin Revenue by Application

5.2.1 Global Rho(D) Immune Globulin Historical Revenue by Application (2019-2024)

5.2.2 Global Rho(D) Immune Globulin Forecasted Revenue by Application (2025-2030)

5.2.3 Global Rho(D) Immune Globulin Revenue Market Share by Application (2019-2030)

5.3 Global Rho(D) Immune Globulin Price by Application

5.3.1 Global Rho(D) Immune Globulin Price by Application (2019-2024)

5.3.2 Global Rho(D) Immune Globulin Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Rho(D) Immune Globulin Market Size by Type

6.1.1 US & Canada Rho(D) Immune Globulin Sales by Type (2019-2030)

6.1.2 US & Canada Rho(D) Immune Globulin Revenue by Type (2019-2030)

6.2 US & Canada Rho(D) Immune Globulin Market Size by Application

6.2.1 US & Canada Rho(D) Immune Globulin Sales by Application (2019-2030)

6.2.2 US & Canada Rho(D) Immune Globulin Revenue by Application (2019-2030)

6.3 US & Canada Rho(D) Immune Globulin Market Size by Country

6.3.1 US & Canada Rho(D) Immune Globulin Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Rho(D) Immune Globulin Sales by Country (2019-2030)

6.3.3 US & Canada Rho(D) Immune Globulin Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Rho(D) Immune Globulin Market Size by Type

7.1.1 Europe Rho(D) Immune Globulin Sales by Type (2019-2030)

7.1.2 Europe Rho(D) Immune Globulin Revenue by Type (2019-2030)

7.2 Europe Rho(D) Immune Globulin Market Size by Application

7.2.1 Europe Rho(D) Immune Globulin Sales by Application (2019-2030)

7.2.2 Europe Rho(D) Immune Globulin Revenue by Application (2019-2030)

7.3 Europe Rho(D) Immune Globulin Market Size by Country

7.3.1 Europe Rho(D) Immune Globulin Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Rho(D) Immune Globulin Sales by Country (2019-2030)

7.3.3 Europe Rho(D) Immune Globulin Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Rho(D) Immune Globulin Market Size

8.1.1 China Rho(D) Immune Globulin Sales (2019-2030)

8.1.2 China Rho(D) Immune Globulin Revenue (2019-2030)

8.2 China Rho(D) Immune Globulin Market Size by Application

8.2.1 China Rho(D) Immune Globulin Sales by Application (2019-2030)

8.2.2 China Rho(D) Immune Globulin Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Rho(D) Immune Globulin Market Size by Type

9.1.1 Asia Rho(D) Immune Globulin Sales by Type (2019-2030)

9.1.2 Asia Rho(D) Immune Globulin Revenue by Type (2019-2030)

9.2 Asia Rho(D) Immune Globulin Market Size by Application

9.2.1 Asia Rho(D) Immune Globulin Sales by Application (2019-2030)

9.2.2 Asia Rho(D) Immune Globulin Revenue by Application (2019-2030)

9.3 Asia Rho(D) Immune Globulin Sales by Region

9.3.1 Asia Rho(D) Immune Globulin Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Rho(D) Immune Globulin Revenue by Region (2019-2030)

9.3.3 Asia Rho(D) Immune Globulin Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Rho(D) Immune Globulin Market Size by Type

10.1.1 Middle East, Africa and Latin America Rho(D) Immune Globulin Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Rho(D) Immune Globulin Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Rho(D) Immune Globulin Market Size by Application

10.2.1 Middle East, Africa and Latin America Rho(D) Immune Globulin Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Rho(D) Immune Globulin Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Rho(D) Immune Globulin Sales by Country

10.3.1 Middle East, Africa and Latin America Rho(D) Immune Globulin Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Rho(D) Immune Globulin Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Rho(D) Immune Globulin Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 CSL Behring

11.1.1 CSL Behring Company Information

11.1.2 CSL Behring Overview

11.1.3 CSL Behring Rho(D) Immune Globulin Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 CSL Behring Rho(D) Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 CSL Behring Recent Developments

11.2 Grіfоlѕ

11.2.1 Grіfоlѕ Company Information

11.2.2 Grіfоlѕ Overview

11.2.3 Grіfоlѕ Rho(D) Immune Globulin Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Grіfоlѕ Rho(D) Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Grіfоlѕ Recent Developments

11.3 Bayer

11.3.1 Bayer Company Information

11.3.2 Bayer Overview

11.3.3 Bayer Rho(D) Immune Globulin Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Bayer Rho(D) Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Bayer Recent Developments

11.4 Kedrion Biopharma

11.4.1 Kedrion Biopharma Company Information

11.4.2 Kedrion Biopharma Overview

11.4.3 Kedrion Biopharma Rho(D) Immune Globulin Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Kedrion Biopharma Rho(D) Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Kedrion Biopharma Recent Developments

11.5 Saol Therapeutics

11.5.1 Saol Therapeutics Company Information

11.5.2 Saol Therapeutics Overview

11.5.3 Saol Therapeutics Rho(D) Immune Globulin Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Saol Therapeutics Rho(D) Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Saol Therapeutics Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Rho(D) Immune Globulin Industry Chain Analysis

12.2 Rho(D) Immune Globulin Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Rho(D) Immune Globulin Production Mode & Process

12.4 Rho(D) Immune Globulin Sales and Marketing

12.4.1 Rho(D) Immune Globulin Sales Channels

12.4.2 Rho(D) Immune Globulin Distributors

12.5 Rho(D) Immune Globulin Customers

13 Market Dynamics

13.1 Rho(D) Immune Globulin Industry Trends

13.2 Rho(D) Immune Globulin Market Drivers

13.3 Rho(D) Immune Globulin Market Challenges

13.4 Rho(D) Immune Globulin Market Restraints

14 Key Findings in The Global Rho(D) Immune Globulin Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Rho(D) Immune Globulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of 5 ml

Table 3. Major Manufacturers of 10 ml

Table 4. Global Rho(D) Immune Globulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Rho(D) Immune Globulin Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Rho(D) Immune Globulin Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Rho(D) Immune Globulin Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Rho(D) Immune Globulin Revenue Market Share by Region (2019-2024)

Table 9. Global Rho(D) Immune Globulin Revenue Market Share by Region (2025-2030)

Table 10. Global Rho(D) Immune Globulin Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Rho(D) Immune Globulin Sales by Region (2019-2024) & (K Units)

Table 12. Global Rho(D) Immune Globulin Sales by Region (2025-2030) & (K Units)

Table 13. Global Rho(D) Immune Globulin Sales Market Share by Region (2019-2024)

Table 14. Global Rho(D) Immune Globulin Sales Market Share by Region (2025-2030)

Table 15. Global Rho(D) Immune Globulin Sales by Manufacturers (2019-2024) & (K Units)

Table 16. Global Rho(D) Immune Globulin Sales Share by Manufacturers (2019-2024)

Table 17. Global Rho(D) Immune Globulin Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Rho(D) Immune Globulin Revenue Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Rho(D) Immune Globulin, Industry Ranking, 2022 VS 2023 VS 2024

Table 20. Rho(D) Immune Globulin Price by Manufacturers 2019-2024 (US$/Unit)

Table 21. Global Rho(D) Immune Globulin Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Rho(D) Immune Globulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rho(D) Immune Globulin as of 2023)

Table 23. Global Key Manufacturers of Rho(D) Immune Globulin, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Rho(D) Immune Globulin, Product Offered and Application

Table 25. Global Key Manufacturers of Rho(D) Immune Globulin, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Rho(D) Immune Globulin Sales by Type (2019-2024) & (K Units)

Table 28. Global Rho(D) Immune Globulin Sales by Type (2025-2030) & (K Units)

Table 29. Global Rho(D) Immune Globulin Sales Share by Type (2019-2024)

Table 30. Global Rho(D) Immune Globulin Sales Share by Type (2025-2030)

Table 31. Global Rho(D) Immune Globulin Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Rho(D) Immune Globulin Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Rho(D) Immune Globulin Revenue Share by Type (2019-2024)

Table 34. Global Rho(D) Immune Globulin Revenue Share by Type (2025-2030)

Table 35. Rho(D) Immune Globulin Price by Type (2019-2024) & (US$/Unit)

Table 36. Global Rho(D) Immune Globulin Price Forecast by Type (2025-2030) & (US$/Unit)

Table 37. Global Rho(D) Immune Globulin Sales by Application (2019-2024) & (K Units)

Table 38. Global Rho(D) Immune Globulin Sales by Application (2025-2030) & (K Units)

Table 39. Global Rho(D) Immune Globulin Sales Share by Application (2019-2024)

Table 40. Global Rho(D) Immune Globulin Sales Share by Application (2025-2030)

Table 41. Global Rho(D) Immune Globulin Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Rho(D) Immune Globulin Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Rho(D) Immune Globulin Revenue Share by Application (2019-2024)

Table 44. Global Rho(D) Immune Globulin Revenue Share by Application (2025-2030)

Table 45. Rho(D) Immune Globulin Price by Application (2019-2024) & (US$/Unit)

Table 46. Global Rho(D) Immune Globulin Price Forecast by Application (2025-2030) & (US$/Unit)

Table 47. US & Canada Rho(D) Immune Globulin Sales by Type (2019-2024) & (K Units)

Table 48. US & Canada Rho(D) Immune Globulin Sales by Type (2025-2030) & (K Units)

Table 49. US & Canada Rho(D) Immune Globulin Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Rho(D) Immune Globulin Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Rho(D) Immune Globulin Sales by Application (2019-2024) & (K Units)

Table 52. US & Canada Rho(D) Immune Globulin Sales by Application (2025-2030) & (K Units)

Table 53. US & Canada Rho(D) Immune Globulin Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Rho(D) Immune Globulin Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Rho(D) Immune Globulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Rho(D) Immune Globulin Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Rho(D) Immune Globulin Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Rho(D) Immune Globulin Sales by Country (2019-2024) & (K Units)

Table 59. US & Canada Rho(D) Immune Globulin Sales by Country (2025-2030) & (K Units)

Table 60. Europe Rho(D) Immune Globulin Sales by Type (2019-2024) & (K Units)

Table 61. Europe Rho(D) Immune Globulin Sales by Type (2025-2030) & (K Units)

Table 62. Europe Rho(D) Immune Globulin Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Rho(D) Immune Globulin Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Rho(D) Immune Globulin Sales by Application (2019-2024) & (K Units)

Table 65. Europe Rho(D) Immune Globulin Sales by Application (2025-2030) & (K Units)

Table 66. Europe Rho(D) Immune Globulin Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Rho(D) Immune Globulin Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Rho(D) Immune Globulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Rho(D) Immune Globulin Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Rho(D) Immune Globulin Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Rho(D) Immune Globulin Sales by Country (2019-2024) & (K Units)

Table 72. Europe Rho(D) Immune Globulin Sales by Country (2025-2030) & (K Units)

Table 73. China Rho(D) Immune Globulin Sales by Type (2019-2024) & (K Units)

Table 74. China Rho(D) Immune Globulin Sales by Type (2025-2030) & (K Units)

Table 75. China Rho(D) Immune Globulin Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Rho(D) Immune Globulin Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Rho(D) Immune Globulin Sales by Application (2019-2024) & (K Units)

Table 78. China Rho(D) Immune Globulin Sales by Application (2025-2030) & (K Units)

Table 79. China Rho(D) Immune Globulin Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Rho(D) Immune Globulin Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Rho(D) Immune Globulin Sales by Type (2019-2024) & (K Units)

Table 82. Asia Rho(D) Immune Globulin Sales by Type (2025-2030) & (K Units)

Table 83. Asia Rho(D) Immune Globulin Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Rho(D) Immune Globulin Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Rho(D) Immune Globulin Sales by Application (2019-2024) & (K Units)

Table 86. Asia Rho(D) Immune Globulin Sales by Application (2025-2030) & (K Units)

Table 87. Asia Rho(D) Immune Globulin Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Rho(D) Immune Globulin Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Rho(D) Immune Globulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Rho(D) Immune Globulin Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Rho(D) Immune Globulin Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Rho(D) Immune Globulin Sales by Region (2019-2024) & (K Units)

Table 93. Asia Rho(D) Immune Globulin Sales by Region (2025-2030) & (K Units)

Table 94. Middle East, Africa and Latin America Rho(D) Immune Globulin Sales by Type (2019-2024) & (K Units)

Table 95. Middle East, Africa and Latin America Rho(D) Immune Globulin Sales by Type (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Rho(D) Immune Globulin Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Rho(D) Immune Globulin Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Rho(D) Immune Globulin Sales by Application (2019-2024) & (K Units)

Table 99. Middle East, Africa and Latin America Rho(D) Immune Globulin Sales by Application (2025-2030) & (K Units)

Table 100. Middle East, Africa and Latin America Rho(D) Immune Globulin Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Rho(D) Immune Globulin Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Rho(D) Immune Globulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Rho(D) Immune Globulin Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Rho(D) Immune Globulin Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Rho(D) Immune Globulin Sales by Country (2019-2024) & (K Units)

Table 106. Middle East, Africa and Latin America Rho(D) Immune Globulin Sales by Country (2025-2030) & (K Units)

Table 107. CSL Behring Company Information

Table 108. CSL Behring Description and Major Businesses

Table 109. CSL Behring Rho(D) Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. CSL Behring Rho(D) Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. CSL Behring Recent Developments

Table 112. Grіfоlѕ Company Information

Table 113. Grіfоlѕ Description and Major Businesses

Table 114. Grіfоlѕ Rho(D) Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Grіfоlѕ Rho(D) Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Grіfоlѕ Recent Developments

Table 117. Bayer Company Information

Table 118. Bayer Description and Major Businesses

Table 119. Bayer Rho(D) Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Bayer Rho(D) Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Bayer Recent Developments

Table 122. Kedrion Biopharma Company Information

Table 123. Kedrion Biopharma Description and Major Businesses

Table 124. Kedrion Biopharma Rho(D) Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Kedrion Biopharma Rho(D) Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Kedrion Biopharma Recent Developments

Table 127. Saol Therapeutics Company Information

Table 128. Saol Therapeutics Description and Major Businesses

Table 129. Saol Therapeutics Rho(D) Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. Saol Therapeutics Rho(D) Immune Globulin Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Saol Therapeutics Recent Developments

Table 132. Key Raw Materials Lists

Table 133. Raw Materials Key Suppliers Lists

Table 134. Rho(D) Immune Globulin Distributors List

Table 135. Rho(D) Immune Globulin Customers List

Table 136. Rho(D) Immune Globulin Market Trends

Table 137. Rho(D) Immune Globulin Market Drivers

Table 138. Rho(D) Immune Globulin Market Challenges

Table 139. Rho(D) Immune Globulin Market Restraints

Table 140. Research Programs/Design for This Report

Table 141. Key Data Information from Secondary Sources

Table 142. Key Data Information from Primary Sources

List of Figures

Figure 1. Rho(D) Immune Globulin Product Picture

Figure 2. Global Rho(D) Immune Globulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Rho(D) Immune Globulin Market Share by Type in 2023 & 2030

Figure 4. 5 ml Product Picture

Figure 5. 10 ml Product Picture

Figure 6. Global Rho(D) Immune Globulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Rho(D) Immune Globulin Market Share by Application in 2023 & 2030

Figure 8. Government Institution

Figure 9. Private Sector

Figure 10. Others

Figure 11. Rho(D) Immune Globulin Report Years Considered

Figure 12. Global Rho(D) Immune Globulin Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Rho(D) Immune Globulin Revenue 2019-2030 (US$ Million)

Figure 14. Global Rho(D) Immune Globulin Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 15. Global Rho(D) Immune Globulin Revenue Market Share by Region (2019-2030)

Figure 16. Global Rho(D) Immune Globulin Sales 2019-2030 ((K Units)

Figure 17. Global Rho(D) Immune Globulin Sales Market Share by Region (2019-2030)

Figure 18. US & Canada Rho(D) Immune Globulin Sales YoY (2019-2030) & (K Units)

Figure 19. US & Canada Rho(D) Immune Globulin Revenue YoY (2019-2030) & (US$ Million)

Figure 20. Europe Rho(D) Immune Globulin Sales YoY (2019-2030) & (K Units)

Figure 21. Europe Rho(D) Immune Globulin Revenue YoY (2019-2030) & (US$ Million)

Figure 22. China Rho(D) Immune Globulin Sales YoY (2019-2030) & (K Units)

Figure 23. China Rho(D) Immune Globulin Revenue YoY (2019-2030) & (US$ Million)

Figure 24. Asia (excluding China) Rho(D) Immune Globulin Sales YoY (2019-2030) & (K Units)

Figure 25. Asia (excluding China) Rho(D) Immune Globulin Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Middle East, Africa and Latin America Rho(D) Immune Globulin Sales YoY (2019-2030) & (K Units)

Figure 27. Middle East, Africa and Latin America Rho(D) Immune Globulin Revenue YoY (2019-2030) & (US$ Million)

Figure 28. The Rho(D) Immune Globulin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 29. The Top 5 and 10 Largest Manufacturers of Rho(D) Immune Globulin in the World: Market Share by Rho(D) Immune Globulin Revenue in 2023

Figure 30. Global Rho(D) Immune Globulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 31. Global Rho(D) Immune Globulin Sales Market Share by Type (2019-2030)

Figure 32. Global Rho(D) Immune Globulin Revenue Market Share by Type (2019-2030)

Figure 33. Global Rho(D) Immune Globulin Sales Market Share by Application (2019-2030)

Figure 34. Global Rho(D) Immune Globulin Revenue Market Share by Application (2019-2030)

Figure 35. US & Canada Rho(D) Immune Globulin Sales Market Share by Type (2019-2030)

Figure 36. US & Canada Rho(D) Immune Globulin Revenue Market Share by Type (2019-2030)

Figure 37. US & Canada Rho(D) Immune Globulin Sales Market Share by Application (2019-2030)

Figure 38. US & Canada Rho(D) Immune Globulin Revenue Market Share by Application (2019-2030)

Figure 39. US & Canada Rho(D) Immune Globulin Revenue Share by Country (2019-2030)

Figure 40. US & Canada Rho(D) Immune Globulin Sales Share by Country (2019-2030)

Figure 41. U.S. Rho(D) Immune Globulin Revenue (2019-2030) & (US$ Million)

Figure 42. Canada Rho(D) Immune Globulin Revenue (2019-2030) & (US$ Million)

Figure 43. Europe Rho(D) Immune Globulin Sales Market Share by Type (2019-2030)

Figure 44. Europe Rho(D) Immune Globulin Revenue Market Share by Type (2019-2030)

Figure 45. Europe Rho(D) Immune Globulin Sales Market Share by Application (2019-2030)

Figure 46. Europe Rho(D) Immune Globulin Revenue Market Share by Application (2019-2030)

Figure 47. Europe Rho(D) Immune Globulin Revenue Share by Country (2019-2030)

Figure 48. Europe Rho(D) Immune Globulin Sales Share by Country (2019-2030)

Figure 49. Germany Rho(D) Immune Globulin Revenue (2019-2030) & (US$ Million)

Figure 50. France Rho(D) Immune Globulin Revenue (2019-2030) & (US$ Million)

Figure 51. U.K. Rho(D) Immune Globulin Revenue (2019-2030) & (US$ Million)

Figure 52. Italy Rho(D) Immune Globulin Revenue (2019-2030) & (US$ Million)

Figure 53. Russia Rho(D) Immune Globulin Revenue (2019-2030) & (US$ Million)

Figure 54. China Rho(D) Immune Globulin Sales Market Share by Type (2019-2030)

Figure 55. China Rho(D) Immune Globulin Revenue Market Share by Type (2019-2030)

Figure 56. China Rho(D) Immune Globulin Sales Market Share by Application (2019-2030)

Figure 57. China Rho(D) Immune Globulin Revenue Market Share by Application (2019-2030)

Figure 58. Asia Rho(D) Immune Globulin Sales Market Share by Type (2019-2030)

Figure 59. Asia Rho(D) Immune Globulin Revenue Market Share by Type (2019-2030)

Figure 60. Asia Rho(D) Immune Globulin Sales Market Share by Application (2019-2030)

Figure 61. Asia Rho(D) Immune Globulin Revenue Market Share by Application (2019-2030)

Figure 62. Asia Rho(D) Immune Globulin Revenue Share by Region (2019-2030)

Figure 63. Asia Rho(D) Immune Globulin Sales Share by Region (2019-2030)

Figure 64. Japan Rho(D) Immune Globulin Revenue (2019-2030) & (US$ Million)

Figure 65. South Korea Rho(D) Immune Globulin Revenue (2019-2030) & (US$ Million)

Figure 66. China Taiwan Rho(D) Immune Globulin Revenue (2019-2030) & (US$ Million)

Figure 67. Southeast Asia Rho(D) Immune Globulin Revenue (2019-2030) & (US$ Million)

Figure 68. India Rho(D) Immune Globulin Revenue (2019-2030) & (US$ Million)

Figure 69. Middle East, Africa and Latin America Rho(D) Immune Globulin Sales Market Share by Type (2019-2030)

Figure 70. Middle East, Africa and Latin America Rho(D) Immune Globulin Revenue Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America Rho(D) Immune Globulin Sales Market Share by Application (2019-2030)

Figure 72. Middle East, Africa and Latin America Rho(D) Immune Globulin Revenue Market Share by Application (2019-2030)

Figure 73. Middle East, Africa and Latin America Rho(D) Immune Globulin Revenue Share by Country (2019-2030)

Figure 74. Middle East, Africa and Latin America Rho(D) Immune Globulin Sales Share by Country (2019-2030)

Figure 75. Brazil Rho(D) Immune Globulin Revenue (2019-2030) & (US$ Million)

Figure 76. Mexico Rho(D) Immune Globulin Revenue (2019-2030) & (US$ Million)

Figure 77. Turkey Rho(D) Immune Globulin Revenue (2019-2030) & (US$ Million)

Figure 78. Israel Rho(D) Immune Globulin Revenue (2019-2030) & (US$ Million)

Figure 79. GCC Countries Rho(D) Immune Globulin Revenue (2019-2030) & (US$ Million)

Figure 80. Rho(D) Immune Globulin Value Chain

Figure 81. Rho(D) Immune Globulin Production Process

Figure 82. Channels of Distribution

Figure 83. Distributors Profiles

Figure 84. Bottom-up and Top-down Approaches for This Report

Figure 85. Data Triangulation

Figure 86. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Rho(D) Immune Globulin market? zhanKai

The top companies in the global Rho(D) Immune Globulin market are CSL Behring、Grіfоlѕ、Bayer.

Related Reports

Global Rho(D) Immune Globulin Market Research Report 2025
The global market for Rho(D) Immune Globulin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-01
Pages: 76
USD 2900.00
(Single User License)
Global Rho(D) Immune Globulin Market Research Report 2024
Rho(D) immune globulin (RhIG) is a medication used to prevent Rh isoimmunization in mothers who are Rh negative and to treat idiopathic thrombocytopenic purpura (ITP) in people who are Rh positive. It is often given both during and following pregnancy. It may also be used when Rh negative people are given Rh positive blood. It is given by injection into muscle or a vein. A single dose lasts 2 to 4 weeks.
Published Date: 2024-01-17
Pages: 81
USD 2900.00
(Single User License)
Rho(D) Immune Globulin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Rho(D) immune globulin (RhIG) is a medication used to prevent Rh isoimmunization in mothers who are Rh negative and to treat idiopathic thrombocytopenic purpura (ITP) in people who are Rh positive. It is often given both during and following pregnancy. It may also be used when Rh negative people are given Rh positive blood. It is given by injection into muscle or a vein. A single dose lasts 2 to 4 weeks.
Published Date: 2024-01-10
Pages: 99
USD 3950.00
(Single User License)

Global Rho(D) Immune Globulin Market Research Report 2025
The global market for Rho(D) Immune Globulin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-01
Pages: 76
USD 2900.00 (Single User License)
Global Rho(D) Immune Globulin Market Research Report 2024
Rho(D) immune globulin (RhIG) is a medication used to prevent Rh isoimmunization in mothers who are Rh negative and to treat idiopathic thrombocytopenic purpura (ITP) in people who are Rh positive. It is often given both during and following pregnancy. It may also be used when Rh negative people are given Rh positive blood. It is given by injection into muscle or a vein. A single dose lasts 2 to 4 weeks.
Published: 2024-01-17
Pages: 81
USD 2900.00 (Single User License)
Rho(D) Immune Globulin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Rho(D) immune globulin (RhIG) is a medication used to prevent Rh isoimmunization in mothers who are Rh negative and to treat idiopathic thrombocytopenic purpura (ITP) in people who are Rh positive. It is often given both during and following pregnancy. It may also be used when Rh negative people are given Rh positive blood. It is given by injection into muscle or a vein. A single dose lasts 2 to 4 weeks.
Published: 2024-01-10
Pages: 99
USD 3950.00 (Single User License)